TATYANA KLOCHAN: Open Payments
NPI 1134789910 · CINCINNATI, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,410 in 60 payments from 7 companies in 2025. Trend: 2023 $110 · 2024 $879 · 2025 $1,410
Food & beverage: $1,410
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 18 | $461 |
| ABBVIE INC. | 13 | $381 |
| Otsuka America Pharmaceutical, Inc. | 16 | $334 |
| Axsome Therapeutics, Inc. | 5 | $77 |
| Indivior Inc. | 4 | $68 |
| Alkermes, Inc. | 2 | $52 |
| Braeburn Inc. | 2 | $37 |
Products named: CAPLYTA, VRAYLAR, REXULTI, ABILIFY MAINTENA, Auvelity, SUBLOCADE, BRIXADI, ARISTADA.
Industry payments across OH — which companies pay providers there.
